Atlas Trials

Sergey Orlov, MD

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Sergey Orlov, MD

RecordFirmDate
Efficacy And Safety Of Hydroxychloroquine Combined With Methotrexate, Capecitabine And Bevacizumab Vs. Regorafenib In Participants With Refractory Metastatic Colorectal Cancer With Mutations In RAS Genes (NCT06949982)Sergey Orlov, MD2025-03-17

Track Sergey Orlov, MD automatically

Every clearance here is in the API, with alerts when new ones post.